These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease. Dorer R; Odze RD Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330 [TBL] [Abstract][Full Text] [Related]
24. Daily use of non-steroidal anti-inflammatory drugs is less frequent in patients with Barrett's oesophagus who develop an oesophageal adenocarcinoma. Tsibouris P; Hendrickse MT; Isaacs PE Aliment Pharmacol Ther; 2004 Sep; 20(6):645-55. PubMed ID: 15352913 [TBL] [Abstract][Full Text] [Related]
25. Effect of inflammation on cyclooxygenase (COX)-2 expression in benign and malignant oesophageal cells. Abdalla SI; Sanderson IR; Fitzgerald RC Carcinogenesis; 2005 Sep; 26(9):1627-33. PubMed ID: 15878911 [TBL] [Abstract][Full Text] [Related]
26. Cancer risk in Barrett's oesophagus. Dias Pereira A; Suspiro A; Chaves P Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):915-8. PubMed ID: 18049157 [TBL] [Abstract][Full Text] [Related]
27. Barrett's esophagus: a retrospective analysis of 13 years surveillance. Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769 [TBL] [Abstract][Full Text] [Related]
28. The expression of 8-hydroxydeoxyguanosine in oesophageal tissues and tumours. Räsänen JV; Sihvo EI; Ahotupa MO; Färkkilä MA; Salo JA Eur J Surg Oncol; 2007 Dec; 33(10):1164-8. PubMed ID: 17467227 [TBL] [Abstract][Full Text] [Related]
30. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence. Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; Comber H; McGuigan J; Reynolds JV; Murray LJ Cancer Res; 2006 May; 66(9):4975-82. PubMed ID: 16651456 [TBL] [Abstract][Full Text] [Related]
31. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence]. Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680 [TBL] [Abstract][Full Text] [Related]
32. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus. Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552 [TBL] [Abstract][Full Text] [Related]
33. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526 [TBL] [Abstract][Full Text] [Related]
34. Differential expression of the MAD2, BUB1 and HSP27 genes in Barrett's oesophagus-their association with aneuploidy and neoplastic progression. Doak SH; Jenkins GJ; Parry EM; Griffiths AP; Baxter JN; Parry JM Mutat Res; 2004 Mar; 547(1-2):133-44. PubMed ID: 15013707 [TBL] [Abstract][Full Text] [Related]
35. Cyclooxygenase-2 is expressed frequently and early in Barrett's oesophagus and associated adenocarcinoma. Lagorce C; Paraf F; Vidaud D; Couvelard A; Wendum D; Martin A; Fléjou JF Histopathology; 2003 May; 42(5):457-65. PubMed ID: 12713622 [TBL] [Abstract][Full Text] [Related]
36. Low-grade dysplasia in Barrett's esophagus has a high risk of progression. Lim CH; Treanor D; Dixon MF; Axon AT Endoscopy; 2007 Jul; 39(7):581-7. PubMed ID: 17611911 [TBL] [Abstract][Full Text] [Related]
37. Antireflux surgery normalizes cyclooxygenase-2 expression in squamous epithelium of the distal esophagus. Vallböhmer D; DeMeester SR; Oh DS; Banki F; Kuramochi H; Shimizu D; Hagen JA; Danenberg KD; Danenberg PV; Chandrasoma PT; Peters JH; DeMeester TR Am J Gastroenterol; 2006 Jul; 101(7):1458-66. PubMed ID: 16863546 [TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure. Shirvani VN; Ouatu-Lascar R; Kaur BS; Omary MB; Triadafilopoulos G Gastroenterology; 2000 Mar; 118(3):487-96. PubMed ID: 10702199 [TBL] [Abstract][Full Text] [Related]
39. High-grade dysplasia in Barrett's esophagus is associated with increased expression of calgranulin A and B. Bax DA; Siersema PD; Haringsma J; Kuipers EJ; Vos AJ; Van Dekken H; Van Vliet AH; Kusters JG Scand J Gastroenterol; 2007 Aug; 42(8):902-10. PubMed ID: 17613918 [TBL] [Abstract][Full Text] [Related]
40. Comparison of methylene blue-directed biopsies and four-quadrant biopsies in the detection of high-grade intraepithelial neoplasia and early cancer in Barrett's oesophagus. Gossner L; Pech O; May A; Vieth M; Stolte M; Ell C Dig Liver Dis; 2006 Oct; 38(10):724-9. PubMed ID: 16911879 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]